miR-181 and Metabolic Regulation in the Immune System

被引:39
|
作者
Williams, Adam [1 ]
Henao-Mejia, Jorge [1 ]
Harman, Christian C. D. [2 ]
Flavell, Richard A. [1 ,3 ]
机构
[1] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA
[2] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06520 USA
[3] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA
来源
IMMUNITY AND TOLERANCE | 2013年 / 78卷
关键词
T-CELL DEVELOPMENT; TUMOR-SUPPRESSOR P53; PROTEIN-KINASE B; NEGATIVE REGULATION; GLUCOSE-UPTAKE; HEXOKINASE; PTEN; ACTIVATION; EXPRESSION; PROGRESSION;
D O I
10.1101/sqb.2013.78.020024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Regulation of metabolism is emerging as a central mechanism to control cellular identity and function. Extensive research in the last few years has revealed that the PI3K pathway is at the forefront of establishing metabolic changes required for immune cell growth, proliferation, migration, and differentiation. However, we currently have a limited understanding of how signaling through the PI3K pathway is tightly regulated during immune responses and immune cell development. Although a growing number of miRNAs have been shown to target important metabolic pathways, including the PI3K pathway itself, almost nothing is known regarding metabolic regulation by miRNAs in the context of the immune system. Recently, we revealed that the miR-181 family is a metabolic rheostat in vivo through the nonredundant regulation of PTEN. Over the next few years, additional miRNAs with the capacity to regulate various aspects of metabolism in immune cells are likely to be identified. We propose that these miRNAs will form a network to finely tune cellular metabolic status and that miR-181 will function as the primary metabolic rheostat of this network.
引用
收藏
页码:223 / 230
页数:8
相关论文
共 50 条
  • [1] Regulation of selection and autoimmunity by miR-181 family miRNAs
    Schaffert, Steven
    Wang, Song
    Axtell, Robert
    Newell, Evan
    Steinman, Lawrence
    Davis, Mark
    Chen, Chang-Zheng
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [2] Regulation of miR-181 on chemotherapy-resistant cervical cancer cells
    Liu, Wenlian
    Li, Ping
    Xu, Qian
    Wang, Changxiu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (04): : 4566 - 4573
  • [3] Evolution of the mir-181 microRNA family
    Yang, Zhen
    Wan, Xueshuai
    Gu, Zhuoya
    Zhang, Haohai
    Yang, Xiaobo
    He, Lian
    Miao, Ruoyu
    Zhong, Yang
    Zhao, Haitao
    COMPUTERS IN BIOLOGY AND MEDICINE, 2014, 52 : 82 - 87
  • [4] MiR-181 promotes megakaryocyte differentiation
    Li, Xiaobo
    Gao, Lin
    Howell, Paul
    Owen, Laurie
    Xi, Yaguang
    CANCER RESEARCH, 2011, 71
  • [5] miR-181 regulation of BAX controls cisplatin sensitivity of prostate cancer cells
    Cai, Zhi-Ping
    Tong, Shi-Jun
    Wu, Ya-Pei
    Qu, Lian-Xi
    Ding, Qiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (09): : 10127 - 10133
  • [6] The Role of the MiR-181 Family in Hepatocellular Carcinoma
    Chen, Jinbiao
    Liu, Ken
    Vadas, Mathew A.
    Gamble, Jennifer R.
    McCaughan, Geoffrey W.
    CELLS, 2024, 13 (15)
  • [7] Context dependent analysis of the miR-181 targetome
    Verheyden, N. A.
    Winter, S. J.
    Scholz, A.
    Schmid, T.
    Zarnack, K.
    Krueger, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 124 - 124
  • [8] Novel Insights of the Role of miR-181 in Cardiac Dysfunction, through Mitochondrial Gene Regulation
    Das, Samarjit
    Bedja, Djahida
    Campbell, Nathaniel
    Maitra, Anirban
    Steenbergen, Charles
    CIRCULATION, 2013, 128 (22)
  • [9] MIR-181: A POTENTIAL BIOMARKER OF ACUTE MUSCLE WASTING?
    Bloch, S. A. A.
    Kemp, P. R.
    Griffiths, M. J. D.
    Polkey, M. I.
    THORAX, 2013, 68 : A30 - A31
  • [10] MiR-181 Family Modulates Osteopontin in Glioblastoma Multiforme
    Marisetty, Anantha
    Wei, Jun
    Kong, Ling-Yuan
    Ott, Martina
    Fang, Dexing
    Sabbagh, Aria
    Heimberger, Amy B.
    CANCERS, 2020, 12 (12) : 1 - 16